- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Castrate Resistant Prostate Cancer in Hong Kong
Total 113 results
-
Chinese University of Hong KongTerminated
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
The University of Hong KongUnknownProstatic Hyperplasia | Prostate CancerHong Kong
-
Chinese University of Hong KongNot yet recruiting
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongNot yet recruitingProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
Chinese University of Hong KongWithdrawn
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingProstate Cancer | Cardiovascular RiskHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongWithdrawnProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingMRI | Prostate Cancer | PSAHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
Chinese University of Hong KongRecruitingObesity | Breast Cancer | Colorectal Cancer | Prostate CancerHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongRecruitingProstate CancerHong Kong
-
Chinese University of Hong KongJanssen, LPTerminated
-
Chinese University of Hong KongIpsenCompletedProstate CancerHong Kong
-
Chinese University of Hong KongCompletedProstate CancerHong Kong
-
PROCEPT BioRoboticsRecruitingBenign Prostatic Hyperplasia | Localized Prostate CancerLebanon, Hong Kong, United States
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
BayerRecruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Hong Kong, Spain, Taiwan, Australia, Turkey, France, Germany, Hungary, United Kingdom, Singapore, Korea, Republic of, Czechia, Italy, Finland, Israel, Austria, Lithuania, Poland, Russian Federation
-
Astellas Pharma IncActive, not recruitingProgressive Metastatic Prostate CancerChina, Hong Kong, Korea, Republic of, Taiwan
-
Astellas Pharma Singapore Pte. Ltd.CompletedProstate CancerHong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
Ferring PharmaceuticalsFerring Pharmaceuticals Korea, Ltd.CompletedProstate CancerKorea, Republic of
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Germany, United States, Puerto Rico, Israel, Australia, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania
-
VA Office of Research and DevelopmentActive, not recruitingNewly Diagnosed Oligometastatic Prostate CancerUnited States
-
St. Barnabas Medical CenterUnknownProstate CancerUnited States
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
University of California, IrvineUniversity of California, Los Angeles; Cedars-Sinai Medical Center; VA Long Beach... and other collaboratorsRecruiting
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Boehringer IngelheimCompletedProstatic Neoplasms, Castration-ResistantKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Singapore, Hong Kong, Netherlands
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
VA Office of Research and DevelopmentRecruitingProstate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Myriad Genetic Laboratories, Inc.Recruiting
-
Translational Oncology Research InternationalGenentech, Inc.Completed